Jiang C, O'Connor S P, Fang S L, Wang K X, Marshall J, Williams J L, Wilburn B, Echelard Y, Cheng S H
Genzyme Corporation, Framingham, MA 01701-9322, USA.
Hum Gene Ther. 1998 Jul 20;9(11):1531-42. doi: 10.1089/hum.1998.9.11-1531.
Systematic analysis of a large number of different cationic lipids has led to the identification of novel structures (GL-67) and formulations of cationic lipid:plasmid DNA (pDNA) complexes that facilitate high levels of gene expression in lungs of mice. However, despite significant improvement in gene transfer activity, we show here that the efficiency of GL-67-mediated gene transduction of intact airway epithelia is still relatively low. Administration of GL-67:pCF1-CFTR (encoding the cystic fibrosis transmembrane conductance regulator) complexes into the nasal epithelium of cystic fibrosis (CF) transgenic mice resulted only in marginal correction of the ion transport defects. Measurements of nasal potential differences (PD) showed no correction of the sodium (Na+) transport defect, and only partial restitution of the chloride (Cl-) transport defect was achieved in a small proportion of the animals after perfusion of the nasal epithelium with the complexes. Furthermore, in contrast to results obtained following instillation of GL-67:pDNA complexes into the lungs of mice, perfusion of GL-67:pDNA into the nasal epithelium resulted only in a moderate enhancement of gene transduction activity relative to that attained with naked pDNA alone. To determine the basis for this low efficiency of transfection, a series of studies was conducted to identify some of the barriers governing cationic lipid-mediated gene transfer to the airway epithelium. We show here that the transfection activity of GL-67 was affected by the polarization, differentiation, and proliferative state of the cells. Diminished transfection activity was observed with nonmitotic, highly polarized and differentiated airway epithelial cells. This observed reduction in gene expression with nonmitotic cells was determined to be due in part to inefficient nuclear translocation of the pDNA from the cytoplasm. Together these data indicate that much improvement in the ability of cationic lipids to transfect polarized and differentiated airway epithelial cells is a necessary prerequisite for effective cationic lipid-mediated gene therapy of airway diseases such as CF.
对大量不同阳离子脂质进行系统分析后,已鉴定出新型结构(GL - 67)以及阳离子脂质与质粒DNA(pDNA)复合物的配方,这些复合物可促进小鼠肺部高水平的基因表达。然而,尽管基因转移活性有显著提高,但我们在此表明,GL - 67介导的完整气道上皮细胞基因转导效率仍然相对较低。将GL - 67:pCF1 - CFTR(编码囊性纤维化跨膜电导调节因子)复合物施用于囊性纤维化(CF)转基因小鼠的鼻上皮,仅导致离子转运缺陷得到轻微纠正。鼻电位差(PD)测量显示钠(Na +)转运缺陷未得到纠正,在用复合物灌注鼻上皮后,仅在一小部分动物中实现了氯(Cl -)转运缺陷的部分恢复。此外,与将GL - 67:pDNA复合物滴入小鼠肺部后获得的结果相反,将GL - 67:pDNA灌注到鼻上皮中,相对于单独使用裸pDNA,仅导致基因转导活性适度增强。为了确定这种低转染效率的原因,进行了一系列研究以识别一些控制阳离子脂质介导基因转移至气道上皮的障碍。我们在此表明,GL - 67的转染活性受细胞的极化、分化和增殖状态影响。在非有丝分裂、高度极化和分化的气道上皮细胞中观察到转染活性降低。已确定非有丝分裂细胞中基因表达的这种降低部分是由于pDNA从细胞质向细胞核的转运效率低下所致。这些数据共同表明,阳离子脂质转染极化和分化气道上皮细胞的能力有很大提高是有效进行阳离子脂质介导的气道疾病(如CF)基因治疗的必要前提。